Agent for treatment of cisplatin-resistant cancer

Details Agent for treatment of cisplatin-resistant cancer Agent for treatment of cisplatin-resistant cancer

2006-07-31

2008-12-02

Hartley, Michael G. (Department: 1618)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heavy metal containing doai

C424S776000

Reexamination Certificate

active

07459482

ABSTRACT:
Preparation of a lipophilic platinum complex being dissolved or suspended in an iodized poppyseed oil fatty acid ethyl ester is useful as an agent for treatment of cisplatin-resistant cancers.

REFERENCES:
patent: 4562275 (1985-12-01), Speer et al.
patent: 5384127 (1995-01-01), Perez-Soler et al.
patent: 6613799 (2003-09-01), Maeda et al.
patent: 193936 (1986-09-01), None
Fujiyama et al. (British J. of Cancer (2003) 89, 1614-1619.
www.stJude.org/solid-tumor 2-pages (Apr. 2003).
Kishimoto et al., Biol. Pharm Bull. Apr. 2000;23(3):344-8.
Kishimoto et al., Biol. Pharm Bull. Apr. 2000;23(4):487-91.
Kishimoto et al., Jpn. J. Cancer Res. 91, 1326-1332, Dec. 2000.
Kishimoto, S., et al., Jpn. J. Cancer Res., vol. 91, No. 12, pp. 1326-1332, Dec. 2000.
Kishimoto, S., et al., Jpn. J. Cancer Res., vol. 91, No. 1, pp. 99-104, Jan. 2000.
Miyazawa, K. et al., Drug Delivery Syst., vol. 14, No. 5, pp. 401-405, 1999.
Jpn. J. Cancer Chemother., vol. 10, pp. 2442-2452, (1983), (English abstract).
Goddard et al., Ann. Of Onocoloty, vol. 2, pp. 535-540, (1991).
Twentyman et al., Cancer Research, vol. 52, pp. 5674-5680, (1992).
Han et al., Cancer Research, vol. 53, pp. 4913-4919, (1993).
Biochemical Pharmacology, vol. 30, No. 19, pp. 2721-2723, (1981).
Eichholz-Wirth et al., Br. J. Cancer, vol. 54, pp. 239-243. (1986).
Metcalfe et al., Cancer Letters, vol. 31, pp. 163-169, (1986).
Rixe et al., Bio. Pharm., vol. 52, pp. 1855-1865, (1996).
Perez-Soler et a., Cancer Research, vol. 48, pp. 4509-4512, (1988).
Drug Delivery Systems, vol. 5, pp. 243-247, (1990), (English abstract).
J. Jpn. Soc. Cancer Ther., vol. 27, pp. 49-58, (1992), (English abstract).
Kishimoto et al., Reg. Cancer Treat., vol. 1-2, pp. 25-29, (1992).
Kishimoto et al., Biol. Pharm. Bull., vol. 23, No. 3, pp. 334-348, (2000).
Kishimoto et al., Biol. Pharm. Bull., vol. 23, No. 4, pp. 487-491, (2000).
Heike et al., Cancer Chemother. Pharmacol., vol. 35, pp. 200-204, (1995).

Affiliated with

Also associated with

Rating

Agent for treatment of cisplatin-resistant cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for treatment of cisplatin-resistant cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for treatment of cisplatin-resistant cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4041857